Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

1(20%)

Results Posted

0%(0 trials)

Terminated

1(20%)

Phase Distribution

Ph phase_1

20%

Ph not_applicable

40%

Ph phase_3

20%

Ph phase_4

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

1(20.0%)

Phase 3Large-scale testing

1(20.0%)

Phase 4Post-market surveillance

1(20.0%)

N/ANon-phased studies

2(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Terminated(1)

Detailed Status

Completed2

Not yet recruiting1

Recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (20.0%)

Phase 31 (20.0%)

Phase 41 (20.0%)

N/A2 (40.0%)

Trials by Status

not_yet_recruiting120%

recruiting120%

terminated120%

completed240%

Recent Activity

1 active trials

Showing 5 of 5

not_yet_recruitingphase_3

HFrEF Polypill in Sri Lanka RCT

NCT07569640

recruitingnot_applicable

Free Time For Wellness 2+

NCT06654843

completedphase_1

Heart Failure With Reduced Ejection Fraction Polypill Implementation Strategy in Sri Lanka

NCT06831864

completednot_applicable

Fit Plus: Assessing the Impact of a School-based Intervention on Toilet Quality

NCT03204175

terminatedphase_4

Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study)

NCT01820078

Clinical Trials (5)

Showing 5 of 5 trials

NCT07569640Phase 3

HFrEF Polypill in Sri Lanka RCT

Not Yet Recruiting

NCT06654843Not Applicable

Free Time For Wellness 2+

Recruiting

NCT06831864Phase 1

Heart Failure With Reduced Ejection Fraction Polypill Implementation Strategy in Sri Lanka

Completed

NCT03204175Not Applicable

Fit Plus: Assessing the Impact of a School-based Intervention on Toilet Quality

Completed

NCT01820078Phase 4

Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study)

Terminated

All 5 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 5